- Home
- IR vs COR Comparison
IR vs COR Comparison
Compare IR & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IR
- COR
- Stock Information
- Founded
- IR 1859
- COR 2001
- Country
- IR United States
- COR United States
- Employees
- IR N/A
- COR N/A
- Industry
- IR Industrial Machinery/Components
- COR Other Pharmaceuticals
- Sector
- IR Industrials
- COR Health Care
- Exchange
- IR Nasdaq
- COR Nasdaq
- Market Cap
- IR 40.1B
- COR 44.7B
- IPO Year
- IR N/A
- COR N/A
- Fundamental
- Price
- IR $103.50
- COR $243.69
- Analyst Decision
- IR Buy
- COR Buy
- Analyst Count
- IR 13
- COR 11
- Target Price
- IR $102.23
- COR $265.91
- AVG Volume (30 Days)
- IR 2.2M
- COR 1.3M
- Earning Date
- IR 10-31-2024
- COR 11-06-2024
- Dividend Yield
- IR 0.08%
- COR 0.86%
- EPS Growth
- IR 9.29
- COR N/A
- EPS
- IR 2.05
- COR 7.53
- Revenue
- IR $7,157,800,000.00
- COR $293,958,599,000.00
- Revenue This Year
- IR $8.75
- COR $8.69
- Revenue Next Year
- IR $6.41
- COR $6.19
- P/E Ratio
- IR $50.30
- COR $32.24
- Revenue Growth
- IR 7.18
- COR 12.12
- 52 Week Low
- IR $69.46
- COR $195.83
- 52 Week High
- IR $105.63
- COR $251.56
- Technical
- Relative Strength Index (RSI)
- IR 58.51
- COR 54.11
- Support Level
- IR $99.84
- COR $237.48
- Resistance Level
- IR $105.63
- COR $244.29
- Average True Range (ATR)
- IR 1.88
- COR 4.50
- MACD
- IR 0.07
- COR -0.49
- Stochastic Oscillator
- IR 77.43
- COR 49.13
About IR Ingersoll Rand Inc.
Ingersoll Rand was formed through the merger of Gardner Denver and Ingersoll Rand's industrial segment. The firm's portfolio consists of two business lines: industrial technologies and services, and precision and science technologies. Ingersoll Rand serves a variety of end markets, including industrial, medical, and energy. Its broad portfolio of products includes compression, blower and vacuum, and fluid management. Ingersoll Rand generated roughly $6.9 billion in revenue in 2023.
About COR Cencora Inc.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.